Janux Therapeutics
JANX
17.92
+1.13
+6.73%
Janux Therapeutics
US · JANX
#3187 by market cap
Listed 2021
17.92
+1.13
+6.73%
Live - 5344 symbols - heartbeat 458s ago
· 2026-10-08 08:14
Pre-market
18.42
+2.79%
After-hours
18.50
+3.24%
Overnight
17.91
-0.06%
- Market cap
- 1.10B
- P/E (TTM)i
- -10.93
- P/Bi
- 1.18
- EPSi
- -1.83
- Div yieldi
- 0.00%
- 52W posi
- 25%
Reader sentiment
Are you bullish or bearish on JANX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 11 analysts
Buy
Avg price target
34.22 +91.0%
Price target rangecurrent 17.92
Low14.00
Avg34.22
High60.00
Buy 91%
Hold 0%
Sell 9%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-08-24 | Wolfe Research | -- | BUY | 23.00 |
| 2026-08-13 | William Blair | -- | BUY | -- |
| 2026-08-11 | Stifel | -- | BUY | 35.00 |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-08-07 | LifeSci Capital | -- | BUY | 60.00 |
| 2026-08-07 | William Blair | -- | BUY | -- |
| 2026-08-07 | JonesTrading | -- | BUY | 28.00 |
| 2026-08-07 | Piper Sandler | -- | BUY | 26.00 |
| 2026-08-07 | BofA Securities | -- | BUY | 22.00 |
| 2026-08-07 | Truist Financial | -- | BUY | -- |
| 2026-08-07 | Stifel | -- | BUY | 35.00 |
| 2026-08-07 | Barclays | -- | SELL | 14.00 |
| 2026-08-06 | Guggenheim | -- | BUY | 55.00 |
| 2026-06-25 | Truist Financial | -- | BUY | 26.00 |
| 2026-05-11 | Evercore | -- | BUY | 22.00 |
| 2026-05-11 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-05-09 | LifeSci Capital | -- | BUY | 60.00 |
| 2026-05-08 | TD Cowen | -- | BUY | -- |
| 2026-05-08 | LifeSci Capital | -- | BUY | 60.00 |
| 2026-05-08 | JonesTrading | -- | BUY | 28.00 |
| 2026-05-08 | Piper Sandler | -- | BUY | 26.00 |
| 2026-05-08 | BofA Securities | -- | BUY | 21.00 |
| 2026-05-08 | Wedbush | -- | BUY | 36.00 |
| 2026-05-08 | Barclays | -- | SELL | 14.00 |
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Barclays moved from Buy to Sell on 2026-04-20.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-04-20 | Barclays | BUY → SELL | 14.00 |
Quote time 2026-10-08 08:14:51 · For reference only, not investment advice and not tailored to your situation.